Literature DB >> 33998274

Resolving discordant CYP2D6 genotyping results in Thai subjects: platform limitations and novel haplotypes.

Yaowaluck Hongkaew1, Wendy Y Wang2, Roger Gaedigk2, Chonlaphat Sukasem3, Andrea Gaedigk2,4.   

Abstract

Aim: Several CYP2D6 Luminex xTAG genotype calls were identified as inconsistent or suspicious among Thai subjects and further characterized to identify the root causes. Material & methods: Forty-eight subjects were followed-up with long-range-PCR, quantitative copy number assays and/or Sanger sequencing.
Results: Most of the Luminex-duplication calls were either negative or had hybrid structures involving CYP2D6*36 in various configurations. Ten samples were inaccurately called as CYP2D6*2, *29 or *35 alleles. Sequencing revealed three novel haplotypes, CYP2D6*142, *143 and *144 of which two are nonfunctional.
Conclusion: The Luminex platform produced a relatively high number of false genotype calls for Thai subjects. Our findings underscore the need for the systematic characterization of the CYP2D6 locus in diverse populations and rigorous platform validation.

Entities:  

Keywords:  CYP2D6; Luminex xTAG; Thai; genotype; risperidone

Mesh:

Substances:

Year:  2021        PMID: 33998274      PMCID: PMC8212855          DOI: 10.2217/pgs-2021-0013

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.638


  36 in total

1.  Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.

Authors:  Andrea Gaedigk; Amy Turner; Robin E Everts; Stuart A Scott; Praful Aggarwal; Ulrich Broeckel; Gwendolyn A McMillin; Roberta Melis; Erin C Boone; Victoria M Pratt; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2019-08-09       Impact factor: 5.568

2.  Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.

Authors:  Chad A Bousman; Heather Zierhut; Daniel J Müller
Journal:  Clin Pharmacol Ther       Date:  2019-04-20       Impact factor: 6.875

Review 3.  Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.

Authors:  Chad Bousman; Abdullah Al Maruf; Daniel J Müller
Journal:  Curr Opin Psychiatry       Date:  2019-01       Impact factor: 4.741

4.  Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.

Authors:  Yuka Muroi; Takahiro Saito; Masamitsu Takahashi; Kanako Sakuyama; Yui Niinuma; Miyabi Ito; Chiharu Tsukada; Kiminori Ohta; Yasuyuki Endo; Akifumi Oda; Noriyasu Hirasawa; Masahiro Hiratsuka
Journal:  Drug Metab Pharmacokinet       Date:  2014-03-18       Impact factor: 3.614

5.  Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016.

Authors:  Anitha Saravanakumar; Armin Sadighi; Rachel Ryu; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

6.  Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.

Authors:  Ian R McGrane; Joshua G Loveland
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-02-12       Impact factor: 2.576

Review 7.  PharmVar GeneFocus: CYP2D6.

Authors:  Charity Nofziger; Amy J Turner; Katrin Sangkuhl; Michelle Whirl-Carrillo; José A G Agúndez; John L Black; Henry M Dunnenberger; Gualberto Ruano; Martin A Kennedy; Michael S Phillips; Houda Hachad; Teri E Klein; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-12-09       Impact factor: 6.875

8.  Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.

Authors:  Natchaya Vanwong; Nattawat Ngamsamut; Yaowaluck Hongkaew; Nopphadol Nuntamool; Apichaya Puangpetch; Montri Chamnanphon; Ananya Sinrachatanant; Penkhae Limsila; Chonlaphat Sukasem
Journal:  Drug Metab Pharmacokinet       Date:  2016-02-12       Impact factor: 3.614

9.  Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.

Authors:  Takahiro Saito; Evelyn Marie Gutiérrez Rico; Aoi Kikuchi; Akira Kaneko; Masaki Kumondai; Fumika Akai; Daisuke Saigusa; Akifumi Oda; Noriyasu Hirasawa; Masahiro Hiratsuka
Journal:  Drug Metab Pharmacokinet       Date:  2018-08-25       Impact factor: 3.614

10.  Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.

Authors:  Andrea Gaedigk; Lazara Karelia Montane Jaime; Joseph S Bertino; Anick Bérard; Victoria M Pratt; L Dianne Bradfordand; J Steven Leeder
Journal:  Front Pharmacol       Date:  2010-10-04       Impact factor: 5.810

View more
  3 in total

Review 1.  Keeping pace with CYP2D6 haplotype discovery: innovative methods to assign function.

Authors:  Karen E Brown; Jack W Staples; Erica L Woodahl
Journal:  Pharmacogenomics       Date:  2022-01-27       Impact factor: 2.533

2.  Methodology for clinical genotyping of CYP2D6 and CYP2C19.

Authors:  Beatriz Carvalho Henriques; Avery Buchner; Xiuying Hu; Yabing Wang; Vasyl Yavorskyy; Keanna Wallace; Rachael Dong; Kristina Martens; Michael S Carr; Bahareh Behroozi Asl; Joshua Hague; Sudhakar Sivapalan; Wolfgang Maier; Mojca Z Dernovsek; Neven Henigsberg; Joanna Hauser; Daniel Souery; Annamaria Cattaneo; Ole Mors; Marcella Rietschel; Gerald Pfeffer; Stacey Hume; Katherine J Aitchison
Journal:  Transl Psychiatry       Date:  2021-11-22       Impact factor: 6.222

3.  CYP2D6 gene resequencing in the Malagasy, a population at the crossroads between Asia and Africa: a pilot study.

Authors:  E Ricky Chan; Rajeev K Mehlotra; Karim A Pirani; Arsene C Ratsimbasoa; Scott M Williams; Andrea Gaedigk; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2022-03-01       Impact factor: 2.533

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.